Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney V Fletcher

Showing results (71-80 of 162) with videos related to

Pageof 17
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|August 19, 2020
Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)Omalla A Olwenyi, Shetty Ravi Dyavar, Arpan Acharya, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2018
Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ARTOwain Roberts, Rajith K R Rajoli, David J Back, et al.
Journal of Neuroscience Methods|April 28, 2023
A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurementJohid R Malik, Courtney V Fletcher, Anthony T Podany, et al.
The Pediatric Infectious Disease Journal|September 19, 2002
Efavirenz liquid formulation in human immunodeficiency virus-infected childrenStuart E Starr, Courtney V Fletcher, Stephen A Spector, et al.
Clinical Pharmacology and Therapeutics|March 22, 2002
Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infectionSibylle Grub, Patricia Delora, Eric Lüdin, et al.
The Pediatric Infectious Disease Journal|September 19, 2014
Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020ARichard M Rutstein, Pearl Samson, Terry Fenton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359Courtney V Fletcher, Marcia A Testa, Richard C Brundage, et al.
Frontiers in Pharmacology|April 29, 2026
CYP2B6 polymorphisms and suicidal behaviour in people living with HIV treated with efavirenz-containing combination antiretroviral therapy: a global case-control studyAlejandro Arenas-Pinto, Jacqueline Nordwall, Dianne Carey, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2019
Assessing the lymphoid tissue bioavailability of antiretrovirals in human primary lymphoid endothelial cells and in miceShetty Ravi Dyavar, Nagsen Gautam, Anthony T Podany, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2021
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic optionsShetty Ravi Dyavar, Rahul Singh, Rohini Emani, et al.
Pageof 17

Showing results (71-80 of 162) with videos related to

Sort By:
Pageof 17
Journal of Molecular Medicine (Berlin, Germany)|August 19, 2020
Immuno-epidemiology and pathophysiology of coronavirus disease 2019 (COVID-19)Omalla A Olwenyi, Shetty Ravi Dyavar, Arpan Acharya, et al.
The Journal of Antimicrobial Chemotherapy|January 25, 2018
Physiologically based pharmacokinetic modelling prediction of the effects of dose adjustment in drug-drug interactions between levonorgestrel contraceptive implants and efavirenz-based ARTOwain Roberts, Rajith K R Rajoli, David J Back, et al.
Journal of Neuroscience Methods|April 28, 2023
A novel 4-cell in-vitro blood-brain barrier model and its characterization by confocal microscopy and TEER measurementJohid R Malik, Courtney V Fletcher, Anthony T Podany, et al.
The Pediatric Infectious Disease Journal|September 19, 2002
Efavirenz liquid formulation in human immunodeficiency virus-infected childrenStuart E Starr, Courtney V Fletcher, Stephen A Spector, et al.
Clinical Pharmacology and Therapeutics|March 22, 2002
Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infectionSibylle Grub, Patricia Delora, Eric Lüdin, et al.
The Pediatric Infectious Disease Journal|September 19, 2014
Long-term safety and efficacy of atazanavir-based therapy in HIV-infected infants, children and adolescents: the Pediatric AIDS Clinical Trials Group Protocol 1020ARichard M Rutstein, Pearl Samson, Terry Fenton, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 27, 2005
Four measures of antiretroviral medication adherence and virologic response in AIDS clinical trials group study 359Courtney V Fletcher, Marcia A Testa, Richard C Brundage, et al.
Frontiers in Pharmacology|April 29, 2026
CYP2B6 polymorphisms and suicidal behaviour in people living with HIV treated with efavirenz-containing combination antiretroviral therapy: a global case-control studyAlejandro Arenas-Pinto, Jacqueline Nordwall, Dianne Carey, et al.
The Journal of Antimicrobial Chemotherapy|July 24, 2019
Assessing the lymphoid tissue bioavailability of antiretrovirals in human primary lymphoid endothelial cells and in miceShetty Ravi Dyavar, Nagsen Gautam, Anthony T Podany, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 21, 2021
Role of toll-like receptor 7/8 pathways in regulation of interferon response and inflammatory mediators during SARS-CoV2 infection and potential therapeutic optionsShetty Ravi Dyavar, Rahul Singh, Rohini Emani, et al.
Pageof 17